anx_ANNEX__table_1__row_5__cell_2
5. Clinical Investigation: (a) Manufacturer, where applicable authorised representative (see fields under 1. Actor); (b) Device (see fields under 2. Device); (c) Title of investigation; (d) Protocol number; (e) Primary objective; (f) Competent Authority Contact for this Clinical Investigation; (g) Decisions taken by Competent Authority pursuant to Article 15(6), date of decision and grounds; (h) Early termination on safety grounds pursuant to Article 15(7), date of decision and grounds.
← anx_ANNEX__table_1__row_5__cell_1 · All articles · anx_ANNEX__table_1__row_6 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-05 · Text as adopted (Official Journal); later amendments are not incorporated in this text.